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INTRODUCTION 
 Despite controversy about the potential for the 
development of dependence in relation to ecstasy [1], some 
people do experience problems with ecstasy use, and full 
case reports of dependence have been identified [2]. The 
Severity of Dependence Scale (SDS) is a brief, five-item 
screening instrument that has demonstrated validity in 
identifying cases of DSM cannabis, amphetamine, cocaine 
and benzodiazepine dependence. This study aimed to 
determine a cut-off score on the SDS that could provide a 
useful indication of individuals that are potentially ecstasy 
dependent according to DSM criteria. 
METHODS 
 Interviews were conducted as part of the Ecstasy and 
Related Drugs Reporting System, a surveillance system for 
the ecstasy market [3]. A total of 198 participants were 
recruited through a purposive sampling strategy. Inclusion 
criteria required participants to be at least 16, and to have 
used ‘ecstasy’ at least monthly in the preceding six months. 
Caseness (dependence) was assessed using the Composite 
International Diagnostic Interview (Short Form: CIDI-SF). 
This provided assessment of past-year DSM dependence 
symptoms, with the exception of withdrawal [4]. As some 
controversy exists over the status of the dependence 
syndrome for ecstasy [1], a conservative approach was 
adopted, whereby symptoms relating to lack of control over 
use (using in larger amounts or for longer than intended) and 
use interfering with role function were only scored positively 
if this occurred at least monthly in the preceding year. 
Diagnostic efficiency measures were calculated for each 
score on the SDS in identifying caseness. 
RESULTS 
 The sample had a mean age of 23 years (range 17-47), 
and 57% (95%CI 50-64) were male. Mean ecstasy use was 
17 days of the past 180 (SD=14, range 6-100). None were 
engaged in drug treatment. Area under the curve for the 
receiver operating characteristic was 0.76 (95%CI: 0.66-
0.85; nonparametric p<0.001), suggesting that the SDS has 
good diagnostic utility. The Youden index (sensitivity + 
specificity -1) was used to identify an optimal cut-off, as the  
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maxima of this index represents the score that best balances 
sensitivity and specificity. This was apparent at an SDS 
value of 3, which correctly classified 73% of cases, and 
identified 63% of true cases while ensuring that only 25% of 
real non-cases were screened positive. To examine validity 
of the identified cut-off, participants were categorised into 
negative (SDS<3; n=135) and positive (SDS3; n=63) 
groups. Univariate logistic regression models demonstrated 
that those screened positive consumed ecstasy more 
frequently, in larger amounts, and in binge patterns, and 
reported greater rates of social and role responsibility 
problems relating to use. Those screened positive were also 
more likely to drive under the influence of ecstasy, engage in 
high-risk alcohol use and experience clinical levels of 
psychological distress. 
DISCUSSION AND CONCLUSIONS 
 Approximately one-fifth of this sample of regular ecstasy 
users were ecstasy dependent according to the DSM. This is 
comparable with studies of sentinel samples of ecstasy users 
internationally using different instruments [5-7]. This 
demonstrates that the experience of problems relating to 
ecstasy may be more common than would be expected on the 
basis of presentations to drug treatment – just 53 per million 
adult population in Australia in 2005/06, compared to 35,500 
per million reporting recent ecstasy use [8] – and 
underscores the importance of screening for problems with 
use. 
 An SDS cut-off of 3 provides a good balance between 
sensitivity and specificity, and validly identifies individuals 
that are experiencing problems with their ecstasy use. For 
research applications, a more conservative cut-off (as high as 
5) may be used to identify a more homogeneous group, but 
the lower cut-off is appropriate for clinical applications, 
particularly in light of the brevity of the SDS. 
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